Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KCNA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF259P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ANKRD20A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYSM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRAGC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAMDEC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TP63 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSGA10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANO4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEFV - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPAS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XPO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBC1D19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ECRP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD21L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on